适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 15age old 至 ot applicable（—）
- 性别
- All
入选标准
- •patients with the targeted disease, etc
排除标准
- •Untreated for the disease, etc
研究者
相似试验
未知
2 期
K-104-CR Phase II Exploratory studyHypercholesterolemiaJPRN-jRCT2080222137Kowa Co., Ltd.24
招募中
不适用
A prospective observational preliminary study of Korean medicine treatment for patients with fibromyalgiaKCT0007457Kyung Hee University Oriental Medical Center20
招募中
不适用
A prospective observational preliminary study on Korean medicine treatment for patients with postherpetic neuralgiaDiseases of the nervous systemKCT0007458Kyung Hee University Oriental Medical Center20
未知
1 期
A phase 1 study of K-912, nonrandomized, open label, dose escalation study in Japanese patients with solid tumors.Solid tumorsJPRN-jRCT2080222174Kowa Co., Ltd.30
已完成
1 期
A Phase I/Ib, Study of KAZ954 as a Single Agent and in Combination With Spartalizumab, NZV930 and NIR178 in Patients With Advanced Solid TumorsSolid TumorsJPRN-jRCT2080225114ovartis Pharma. K.K.145